Verde Bio Valuation
| APHD Stock | USD 0.0002 0.0001 100.00% |
Verde Bio seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Verde Bio Holdings from inspecting the company fundamentals such as Shares Outstanding of 254.04 K, return on asset of -0.16, and Price To Sales of 0.94 X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Verde Bio's price fluctuation is out of control at this time. Calculation of the real value of Verde Bio Holdings is based on 3 months time horizon. Increasing Verde Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Verde pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Verde Bio Holdings. Since Verde Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Verde Pink Sheet. However, Verde Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.31E-4 | Hype 1.22E-4 |
The real value of Verde Pink Sheet, also known as its intrinsic value, is the underlying worth of Verde Bio Holdings Company, which is reflected in its stock price. It is based on Verde Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Verde Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Verde Bio Holdings helps investors to forecast how Verde pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Verde Bio more accurately as focusing exclusively on Verde Bio's fundamentals will not take into account other important factors: Verde Bio Total Value Analysis
Verde Bio Holdings is presently forecasted to have valuation of 286.8 K with market capitalization of 412.81 K, debt of 1.07 M, and cash on hands of 126.02 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Verde Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
286.8 K | 412.81 K | 1.07 M | 126.02 K |
Verde Bio Investor Information
The company recorded a loss per share of 1.26. Verde Bio Holdings had not issued any dividends in recent years. The entity had 100:25000 split on the 4th of August 2022. Based on the analysis of Verde Bio's profitability, liquidity, and operating efficiency, Verde Bio Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Verde Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Verde Bio has an asset utilization ratio of 27960.52 percent. This indicates that the Company is making $279.61 for each dollar of assets. An increasing asset utilization means that Verde Bio Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Verde Bio Profitability Analysis
The company reported the previous year's revenue of 456.04 K. Net Loss for the year was (1.58 M) with profit before overhead, payroll, taxes, and interest of 11.54 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Verde Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Verde Bio and how it compares across the competition.
About Verde Bio Valuation
The pink sheet valuation mechanism determines Verde Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Verde Bio. We calculate exposure to Verde Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Verde Bio's related companies.The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. Apogee 21 Holdings, Inc. was founded in 2005 and is based in Wheat Ridge, Colorado. Apogee 21 operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.
8 Steps to conduct Verde Bio's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Verde Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Verde Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Verde Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Verde Bio's revenue streams: Identify Verde Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Verde Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Verde Bio's growth potential: Evaluate Verde Bio's management, business model, and growth potential.
- Determine Verde Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Verde Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Verde Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Verde Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.5 M | |
| Retained Earnings | -7.5 M |
Complementary Tools for Verde Pink Sheet analysis
When running Verde Bio's price analysis, check to measure Verde Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verde Bio is operating at the current time. Most of Verde Bio's value examination focuses on studying past and present price action to predict the probability of Verde Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verde Bio's price. Additionally, you may evaluate how the addition of Verde Bio to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |